… drewqjoseph.45. GSK’s blood cancer drug Blenrep won regulatory approval … other medicines in patients whose cancer has resurged after an earlier … approved in the U.S., European Union, U.K., and other countries …

… non-toxic version with stringent EU regulations on not allowing … is still emerging, the EU has already banned many of … and other chemicals banned under EU regulations, said Dr Maneendra. … especially for those recovering from cancer,” said Dr Maneendra. While …

… patients with multiple myeloma, a cancer marked by remission and relapse … Research Institute, City of Hope Cancer Center, said: “As patients with … of 23 July 2025,6 European Union, Japan (with priority review), China …

… company focused on early skin cancer detection, has raised £ … regulatory milestone: earning an EU MDR Class III CE … waits for essential skin cancer screenings. This scarcity is … technology is redefining early skin cancer detection, improving patient outcomes …

… y Resiliencia – Funded by the European Union NextGenerationEU. Valerie Vanhooren, Co-Founder … , added, “ADCs have transformed cancer treatment; however, the technology has … forefront of developing next-generation cancer therapies. This collaboration marks …

Today, a brief rundown of news involving Eisai, Sarepta Therapeutics and Sandoz, as well as updates from Mural Oncology, Cyprumed and Spruce Bio that you may have missed. After a long regulatory saga, Eisai and Biogen have secured European market …

… follows Skin Analytics’ recent EU MDR Class III CE … clinical decisions on skin cancer without human review. The … Analytics. “Starting with skin cancer, this funding allows us … technology is redefining early skin cancer detection, improving patient outcomes …

Roche announced that the European Commission has approved Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) not …

… follows Skin Analytics’ recent EU MDR Class III CE … clinical decisions on skin cancer without human review. Healthcare … is redefining early skin cancer detection, improving patient outcomes … who want to transform cancer detection forever. Lead image …

… and Young Adults (AYA) cancer patients.  Framework contract in … and supportive care. Yet, cancer survival rates vary from … (AYA) cancer patients and survivors in all EU countries, Norway … before, during and after cancer treatment, while also highlighting …